Glooko, Inc. is a leading global health technology company specializing in diabetes management solutions with a focus on enhancing patient care through innovative digital tools. The flagship product, Glooko XT®, is a certified medical device designed to help individuals manage various types of diabetes, including Type 1, Type 2, and gestational diabetes. This comprehensive platform integrates data from connected insulin pens and glucometers, allowing users to effortlessly track their insulin injections, glucose levels, physical activity, and carbohydrate intake in one convenient application.

Glooko XT® not only facilitates meticulous data collection but also enhances patient-provider communication through telemonitoring capabilities. Healthcare professionals can monitor patient data in real-time, ensuring timely adjustments to treatment plans. The platform is recognized for its compliance with interoperability and security standards for digital medical devices, providing a reliable and efficient tool for diabetes management. By bridging the gap between patients and healthcare teams, Glooko aims to empower users to take charge of their health, promoting better outcomes and a more manageable diabetic lifestyle.